Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is typically 0.07-0.20 ug/mL.
Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.10-0.80 ug/mL.
2 μg of BMP-2, Human (Cat. No. Z02913) was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie Blue staining.
GenScript product showed better activity compared to competitor P
Synonyms | rHuBMP-2; Bone Morphogenetic Protein2; BMP-2; BMP2 |
Description | Human Bone Morphogenetic Protein-2 (BMP-2) is a bone-growth regulatory factor and a member of the transforming growth factor-β (TGF-β) superfamily of proteins. Human Bone Morphogenetic Protein-2 (BMP-2) is synthesized as large precursor molecules, which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or as a heterodimer of two related bone morphogenetic proteins. Recombinant human Bone Morphogenetic Protein-2 (BMP-2) produced in E. coli is a homodimeric, non-glycosylated polypeptide chain containing 115 amino acids and having a molecular mass of 26,018 Da. Human Bone Morphogenetic Protein-2 (BMP-2) is purified by proprietary chromatographic techniques. |
Source | E. coli |
Biological Activity | Recombinant human Bone Morphogenetic Protein-2 (BMP-2) is fully biologically active when compared to standard. The ED50 as determined by the cytolysis of MC3T3-E1 cells is less than 50 ng/ml corresponding to a specific activity of 2.0 x 104 IU/mg. |
Measured Molecular Weight | 26,018 Da |
Purity | Greater than 95.0% as determined by the following methods: (a) Analysis by SEC-HPLC (b) Analysis by reducing and non-reducing SDS-PAGE silver-stained gel |
Formulation | The protein was lyophilized after extensive dialysis against 50mM Acetic acid. |
Reconstitution | It is recommended that the lyophilized rHuBMP-2 be reconstituted in sterile 20 mM HAc (acetic acid) not less than 100 μg/ml, which can then be further diluted to other aqueous solutions. |
Endotoxin Level | Less than 0.1 ng/μg (1 IEU/μg) of Bone Morphogenetic Protein-2 |
Sequence Analysis | The sequence of the first five N-terminal amino acids has been found to be Met-Gln-Ala-Lys-His. |
Storage | Lyophilized recombinant human Bone Morphogenetic Protein-2 (BMP-2) remains stable at room temperature for three weeks, but it is best stored desiccated below -18°C. Upon reconstitution rHuBMP-2 should be stored at 4°C for up to seven days. For long term storage it is recommended that a carrier protein (0.1% HSA or BSA) be added. Avoid repeated freeze-thaw cycles. |
Note | ; |
Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is typically 0.07-0.20 ug/mL.
Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.10-0.80 ug/mL.
2 μg of BMP-2, Human (Cat. No. Z02913) was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie Blue staining.
GenScript product showed better activity compared to competitor P
Cat. No. | Product Name | Quantity | Price |
---|---|---|---|
Z02913-10 |
BMP-2, Human - 10 ug |
$85.00 |
|
Z02913-50 |
BMP-2, Human - 50 ug |
$268.00 |
|
Z02913-1 |
BMP-2, Human - 1 mg |
$1600.00 |
For more documents, please visit "Technical Support".